26 de agosto de 2016 / 5:11 / en un año

BRIEF-Hemispherx Biopharma received approval of its new drug application from ANMAT

Aug 26 (Reuters) - Hemispherx Biopharma Inc

* Received approval of its new drug application from anmat for commercial sale of rintatolimod in argentine republic

* Product will be marketed by GP Pharm, Hemispherx’s commercial partner in Latin America

* Will continue to seek approval in additional Latin American countries

Source text for Eikon:

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below